Association Between Mineralocorticoid Receptor Antagonist Use and Outcome in Myocardial Infarction Patients With Heart Failure

BACKGROUND: There are no studies of mineralocorticoid receptor antagonist (MRA) treatment examining outcome in unselected real‐life patients with myocardial infarction (MI) and heart failure (HF). There is uncertainty regarding effects of MRA in relation to left ventricular ejection fraction (LVEF)...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Am Heart Assoc
Main Authors: Löfman, Ida, Szummer, Karolina, Olsson, Henrik, Carrero, Juan‐Jesus, Lund, Lars H., Jernberg, Tomas
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2018
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6064826/
https://ncbi.nlm.nih.gov/pubmed/29980521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.118.009359
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki